Global Biologic Therapeutics Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Publisher Name :
Date: 10-Feb-2020
No. of pages: 103

Market Overview

The global Biologic Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.8% in the forecast period of 2020 to 2025 and will expected to reach USD 414920 million by 2025, from USD 331750 million in 2019.

The Biologic Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Biologic Therapeutics Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Biologic Therapeutics Drugs market has been segmented into

- Humans

- Avian Cell Culture

- Yeast

- Bacteria

- Insects Cell Culture

- Transgenics

By Application, Biologic Therapeutics Drugs has been segmented into:

- Rheumatoid Arthritis

- Anemia

- Cancer

- Diabetes

- Others

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Biologic Therapeutics Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Biologic Therapeutics Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biologic Therapeutics Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Biologic Therapeutics Drugs market in important countries (regions), including:

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, etc.)

- Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Biologic Therapeutics Drugs Market Share Analysis

Biologic Therapeutics Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biologic Therapeutics Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biologic Therapeutics Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Biologic Therapeutics Drugs are:

- Pfizer

- Aurobindo Pharma

- Merck

- AstraZeneca

- Concord Biotech

- Novartis

- Retractable Technologies

- GlaxoSmithKline

- Smith Medical

- H. Lundbeck

Among other players domestic and global, Biologic Therapeutics Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Biologic Therapeutics Drugs product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Biologic Therapeutics Drugs, with price, sales, revenue and global market share of Biologic Therapeutics Drugs in 2018 and 2019.

Chapter 3, the Biologic Therapeutics Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Biologic Therapeutics Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Biologic Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Biologic Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Biologic Therapeutics Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Market Overview
1.1 Biologic Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biologic Therapeutics Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Humans
1.2.3 Avian Cell Culture
1.2.4 Yeast
1.2.5 Bacteria
1.2.6 Insects Cell Culture
1.2.7 Transgenics
1.3 Market Analysis by Application
1.3.1 Overview: Global Biologic Therapeutics Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Rheumatoid Arthritis
1.3.3 Anemia
1.3.4 Cancer
1.3.5 Diabetes
1.3.6 Others
1.4 Overview of Global Biologic Therapeutics Drugs Market
1.4.1 Global Biologic Therapeutics Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Aurobindo Pharma
2.2.1 Aurobindo Pharma Details
2.2.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Aurobindo Pharma SWOT Analysis
2.2.4 Aurobindo Pharma Product and Services
2.2.5 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Concord Biotech
2.5.1 Concord Biotech Details
2.5.2 Concord Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Concord Biotech SWOT Analysis
2.5.4 Concord Biotech Product and Services
2.5.5 Concord Biotech Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Retractable Technologies
2.7.1 Retractable Technologies Details
2.7.2 Retractable Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Retractable Technologies SWOT Analysis
2.7.4 Retractable Technologies Product and Services
2.7.5 Retractable Technologies Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline SWOT Analysis
2.8.4 GlaxoSmithKline Product and Services
2.8.5 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Smith Medical
2.9.1 Smith Medical Details
2.9.2 Smith Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Smith Medical SWOT Analysis
2.9.4 Smith Medical Product and Services
2.9.5 Smith Medical Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 H. Lundbeck
2.10.1 H. Lundbeck Details
2.10.2 H. Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 H. Lundbeck SWOT Analysis
2.10.4 H. Lundbeck Product and Services
2.10.5 H. Lundbeck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biologic Therapeutics Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biologic Therapeutics Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Biologic Therapeutics Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biologic Therapeutics Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Biologic Therapeutics Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.5 South America Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Biologic Therapeutics Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Biologic Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biologic Therapeutics Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Biologic Therapeutics Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biologic Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.3 UK Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.4 France Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biologic Therapeutics Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biologic Therapeutics Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biologic Therapeutics Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.5 India Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Biologic Therapeutics Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Biologic Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biologic Therapeutics Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biologic Therapeutics Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biologic Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biologic Therapeutics Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Biologic Therapeutics Drugs Price by Type (2015-2020)
11 Global Biologic Therapeutics Drugs Market Segment by Application
11.1 Global Biologic Therapeutics Drugs Sales Market Share by Application (2015-2020)
11.2 Global Biologic Therapeutics Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Biologic Therapeutics Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Biologic Therapeutics Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Biologic Therapeutics Drugs Market Forecast (2021-2025)
12.2.2 Europe Biologic Therapeutics Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biologic Therapeutics Drugs Market Forecast (2021-2025)
12.2.4 South America Biologic Therapeutics Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biologic Therapeutics Drugs Market Forecast (2021-2025)
12.3 Biologic Therapeutics Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Biologic Therapeutics Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Biologic Therapeutics Drugs Market Share Forecast by Type (2021-2025)
12.4 Biologic Therapeutics Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Biologic Therapeutics Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Biologic Therapeutics Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Biologic Therapeutics Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biologic Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biologic Therapeutics Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Biologic Therapeutics Drugs Major Business
Table 9. Pfizer Biologic Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Biologic Therapeutics Drugs Product and Services
Table 12. Pfizer Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Aurobindo Pharma Biologic Therapeutics Drugs Major Business
Table 15. Aurobindo Pharma Biologic Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Aurobindo Pharma SWOT Analysis
Table 17. Aurobindo Pharma Biologic Therapeutics Drugs Product and Services
Table 18. Aurobindo Pharma Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Biologic Therapeutics Drugs Major Business
Table 21. Merck Biologic Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Merck SWOT Analysis
Table 23. Merck Biologic Therapeutics Drugs Product and Services
Table 24. Merck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 26. AstraZeneca Biologic Therapeutics Drugs Major Business
Table 27. AstraZeneca Biologic Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 28. AstraZeneca SWOT Analysis
Table 29. AstraZeneca Biologic Therapeutics Drugs Product and Services
Table 30. AstraZeneca Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Concord Biotech Basic Information, Manufacturing Base and Competitors
Table 32. Concord Biotech Biologic Therapeutics Drugs Major Business
Table 33. Concord Biotech Biologic Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Concord Biotech SWOT Analysis
Table 35. Concord Biotech Biologic Therapeutics Drugs Product and Services
Table 36. Concord Biotech Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis Basic Information, Manufacturing Base and Competitors
Table 38. Novartis Biologic Therapeutics Drugs Major Business
Table 39. Novartis Biologic Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Novartis SWOT Analysis
Table 41. Novartis Biologic Therapeutics Drugs Product and Services
Table 42. Novartis Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Retractable Technologies Basic Information, Manufacturing Base and Competitors
Table 44. Retractable Technologies Biologic Therapeutics Drugs Major Business
Table 45. Retractable Technologies Biologic Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Retractable Technologies SWOT Analysis
Table 47. Retractable Technologies Biologic Therapeutics Drugs Product and Services
Table 48. Retractable Technologies Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 50. GlaxoSmithKline Biologic Therapeutics Drugs Major Business
Table 51. GlaxoSmithKline Biologic Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 52. GlaxoSmithKline SWOT Analysis
Table 53. GlaxoSmithKline Biologic Therapeutics Drugs Product and Services
Table 54. GlaxoSmithKline Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Smith Medical Basic Information, Manufacturing Base and Competitors
Table 56. Smith Medical Biologic Therapeutics Drugs Major Business
Table 57. Smith Medical Biologic Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Smith Medical SWOT Analysis
Table 59. Smith Medical Biologic Therapeutics Drugs Product and Services
Table 60. Smith Medical Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. H. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 62. H. Lundbeck Biologic Therapeutics Drugs Major Business
Table 63. H. Lundbeck Biologic Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 64. H. Lundbeck SWOT Analysis
Table 65. H. Lundbeck Biologic Therapeutics Drugs Product and Services
Table 66. H. Lundbeck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Biologic Therapeutics Drugs Sales by Manufacturer (2018-2019) (MT)
Table 68. Global Biologic Therapeutics Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Biologic Therapeutics Drugs Sales by Regions (2015-2020) (MT)
Table 70. Global Biologic Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 71. Global Biologic Therapeutics Drugs Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Biologic Therapeutics Drugs Sales by Countries (2015-2020) (MT)
Table 73. North America Biologic Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 74. North America Biologic Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Biologic Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 76. Europe Biologic Therapeutics Drugs Sales by Countries (2015-2020) (MT)
Table 77. Europe Biologic Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 78. Europe Biologic Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Biologic Therapeutics Drugs Sales by Regions (2015-2020) (MT)
Table 80. Asia-Pacific Biologic Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Biologic Therapeutics Drugs Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Biologic Therapeutics Drugs Sales by Countries (2015-2020) (MT)
Table 83. South America Biologic Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 84. South America Biologic Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Biologic Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Biologic Therapeutics Drugs Sales by Countries (2015-2020) (MT)
Table 87. Middle East & Africa Biologic Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Biologic Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Biologic Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 90. Global Biologic Therapeutics Drugs Sales by Type (2015-2020) (MT)
Table 91. Global Biologic Therapeutics Drugs Sales Share by Type (2015-2020)
Table 92. Global Biologic Therapeutics Drugs Revenue by Type (2015-2020) (USD Million)
Table 93. Global Biologic Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 94. Global Biologic Therapeutics Drugs Sales by Application (2015-2020) (MT)
Table 95. Global Biologic Therapeutics Drugs Sales Share by Application (2015-2020)
Table 96. Global Biologic Therapeutics Drugs Sales Forecast by Regions (2021-2025) (MT)
Table 97. Global Biologic Therapeutics Drugs Market Share Forecast by Regions (2021-2025)
Table 98. Global Biologic Therapeutics Drugs Sales Forecast by Type (2021-2025) (MT)
Table 99. Global Biologic Therapeutics Drugs Market Share Forecast by Type (2021-2025)
Table 100. Global Biologic Therapeutics Drugs Sales Forecast by Application (2021-2025)
Table 101. Global Biologic Therapeutics Drugs Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Biologic Therapeutics Drugs Picture
Figure 2. Global Sales Market Share of Biologic Therapeutics Drugs by Type in 2019
Figure 3. Humans Picture
Figure 4. Avian Cell Culture Picture
Figure 5. Yeast Picture
Figure 6. Bacteria Picture
Figure 7. Insects Cell Culture Picture
Figure 8. Transgenics Picture
Figure 9. Biologic Therapeutics Drugs Sales Market Share by Application in 2018
Figure 10. Rheumatoid Arthritis Picture
Figure 11. Anemia Picture
Figure 12. Cancer Picture
Figure 13. Diabetes Picture
Figure 14. Others Picture
Figure 15. Global Biologic Therapeutics Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Biologic Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Biologic Therapeutics Drugs Sales Market Share by Manufacturer in 2019
Figure 36. Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Biologic Therapeutics Drugs Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Biologic Therapeutics Drugs Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 41. Global Biologic Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Biologic Therapeutics Drugs Revenue Market Share by Regions (2015-2020)
Figure 43. Global Biologic Therapeutics Drugs Revenue Market Share by Regions in 2018
Figure 44. North America Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 45. Europe Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 47. South America Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 49. North America Biologic Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Biologic Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Figure 51. North America Biologic Therapeutics Drugs Sales Market Share by Countries in 2018
Figure 52. North America Biologic Therapeutics Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Biologic Therapeutics Drugs Revenue Market Share by Countries in 2018
Figure 54. United States Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 55. Canada Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 56. Mexico Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 57. Europe Biologic Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Biologic Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Biologic Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 60. Germany Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 61. UK Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 62. France Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 63. Russia Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 64. Italy Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 65. Asia-Pacific Biologic Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Biologic Therapeutics Drugs Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Biologic Therapeutics Drugs Revenue Market Share by Regions 2019
Figure 68. China Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 69. Japan Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 70. Korea Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 71. India Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 72. Southeast Asia Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 73. South America Biologic Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Biologic Therapeutics Drugs Sales Market Share by Countries in 2019
Figure 75. South America Biologic Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 76. Brazil Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 77. Argentina Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 78. Middle East and Africa Biologic Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Biologic Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Biologic Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 83. Egypt Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 84. Turkey Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 85. South Africa Biologic Therapeutics Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 86. Global Biologic Therapeutics Drugs Sales and Growth Rate (2021-2025) (MT)
Figure 87. Global Biologic Therapeutics Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Biologic Therapeutics Drugs Market Forecast (2021-2025) (MT)
Figure 89. Europe Sales Biologic Therapeutics Drugs Market Forecast (2021-2025) (MT)
Figure 90. Asia-Pacific Sales Biologic Therapeutics Drugs Market Forecast (2021-2025) (MT)
Figure 91. South America Sales Biologic Therapeutics Drugs Market Forecast (2021-2025) (MT)
Figure 92. Middle East & Africa Sales Biologic Therapeutics Drugs Market Forecast (2021-2025) (MT)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs